BioSpace News Archive

BELLUS Health Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other hypersensitization-related disorders, announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will be participating in a fireside chat at the Jefferies Virtual Healthcare Conference.

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will present virtually at two upcoming investor conferences.

ProMIS Neurosciences, Inc. announced that it has initiated commercialization of its COVID-19 serology assay and has appointed Owen Dempsey to lead the commercialization program.

Increased cultivation capacity will enhance the Company’s ability to produce pharmaceutical grade psilocybin at scale

Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Dr. Adaeze Enekwechi will join the firm in June as an Operating Partner.

Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with GT Medical Technologies, Inc., to develop Tumor Treating Fields (TTFields) together with GT Medical Technologies’ GammaTile Surgically Targeted Radiation Therapy (STaRT) for treatment of recurrent glioblastoma (GBM). Novocure’s TTFields are electric fields that disrupt cancer cell division.

ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates, today announced it has appointed Paul M. Peloso , MD, a

Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures

Expansion of management team continues with addition of an industry leader with deep experience in business development, licensing, and strategy in the life-science industry

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that its management team will be presenting at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021.